Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NEW YORK, NY / ACCESSWIRE / March 21, 2019 / Q BioMed (QBIO) and its key technology partners are set to initiate development of an industry-changing diagnostic kit for monitoring glaucoma severity and progression. Pending FDA clearance, which could come sooner than many biotech investors might expect, this kit offers the potential to improve the quality of life for glaucoma sufferers by helping preserve visual function in glaucoma patients through accurate monitoring of disease progression. As a result, this diagnostic offers substantial future value to the Company.
NEW YORK, NY / ACCESSWIRE / March 21, 2019 / Q BioMed (QBIO) and its key technology partners are set to initiate development of an industry-changing diagnostic kit for monitoring glaucoma severity and progression. Pending FDA clearance, which could come sooner than many biotech investors might expect, this kit offers the potential to improve the quality of life for glaucoma sufferers by helping preserve visual function in glaucoma patients through accurate monitoring of disease progression. As a result, this diagnostic offers substantial future value to the Company.
DirectView and DirectView Security Systems have a strong history of installing and maintaining surveillance systems for LBU Lighting. DirectView and LBU Lighting’s business relationship began in 2016 when DirectView was contracted to provide surveillance systems for the retailer’s many showroom locations. DirectView’s extensive expertise, top notch products, installation, and maintenance were all contributing factors when being reselected to provide and install surveillance equipment for the retailer’s new locations.
Nice day here so far. Let's see QBIO return to HoD
that ask is getting so thin!
Very nice QBIO news! Glaucoma afflicts 70 million people
Very nice QBIO news! Glaucoma afflicts 70 million people
QBIO nice news! Based on the novel GDF15 biomarker, this kit's core, platform technology enables more effective measurement and management of glaucoma progression and patient treatment than any current monitoring or therapeutic approaches---a tremendous advantage.
QBIO nice news! Based on the novel GDF15 biomarker, this kit's core, platform technology enables more effective measurement and management of glaucoma progression and patient treatment than any current monitoring or therapeutic approaches---a tremendous advantage.
QBIO nice news out! Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers
QBIO nice news out! Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers https://finance.yahoo.com/news/q-biomeds-industry-changing-diagnostic-113000799.html
Looks like they were reselected for new locations
very impressive news!
This diagnostics kit from QBIO could be a game changer
$DIRV - Big news out w/ contract!
This should look GREAT on the balance sheet
Did you see the contract news today?
QBIO on the breakout boards with news!
Saw their 2016 LBU lighting news. $100k contracts
Yeah, LBU lighting is huge!
This is a nice contract!
Nice! should be a great day for QBIO
Nice QBIO news! While this may be the gold standard in intraocular therapy testing, this method is not truly counted on for diagnostic purposes as it relates to determining progression. As a result, the GDF15-based tool could emerge as the industry's diagnostic standard-bearer and early stage detector.
Big contract news out for $DIRV ! DirectView Wins New Contract with LBU Lighting https://finance.yahoo.com/news/directview-wins-contract-lbu-lighting-125800845.html
Big contract news out for $DIRV ! DirectView Wins New Contract with LBU Lighting https://finance.yahoo.com/news/directview-wins-contract-lbu-lighting-125800845.html
LBU is a big retailer in florida. I see them every day
QBIO news! Glaucoma, which afflicts 70 million people, is diagnosed via a comprehensive eye exam, including visual field testing and tonometry, which measures pressure inside the eye as a means to determine if increased risk factors for glaucoma exist.
Nice DD in the news from QBIO! Considering that no single examination or diagnostic test is able to accurately predict disease progression, QBIO's prospective offering serves an unmet need for millions of patients.
This is big for QBIO - Based on the novel GDF15 biomarker, this kit's core, platform technology enables more effective measurement and management of glaucoma progression and patient treatment than any current monitoring or therapeutic approaches---a tremendous advantage.
Yeah it is. They have to be getting very close
Nice news out on the Diagnostics Kit from QBIO. The Diagnostic Kit Offers Critical, First-of-its-Kind Functionality
NEW YORK, NY / ACCESSWIRE / March 21, 2019 / Q BioMed (QBIO) and its key technology partners are set to initiate development of an industry-changing diagnostic kit for monitoring glaucoma severity and progression. Pending FDA clearance, which could come sooner than many biotech investors might expect, this kit offers the potential to improve the quality of life for glaucoma sufferers by helping preserve visual function in glaucoma patients through accurate monitoring of disease progression. As a result, this diagnostic offers substantial future value to the Company.
QBIO
Link to the QBIO news: https://finance.yahoo.com/news/q-biomeds-industry-changing-diagnostic-113000799.html
Nice QBIO news out! Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers
Can't wait until the acquisition is completed
watching?
once the acquired company comes on the books, this thing is going to skyrocket